{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:57:41Z","timestamp":1786989461375,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.forsciint.2013.03.021","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T19:47:33Z","timestamp":1365277653000},"page":"151-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum"],"prefix":"10.1016","volume":"229","author":[{"given":"Danielle S.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2013.03.021_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.forsciint.2013.03.021_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(01)00548-5","article-title":"Determination of olanzapine in human blood by liquid chromatography-tandem mass spectrometry","volume":"767","author":"Berna","year":"2002","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jat\/33.4.212","article-title":"Determination of olanzapine in whole blood using simple protein precipitation and liquid chromatography\u2013tandem mass spectrometry","volume":"33","author":"Nielsen","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jpba.2006.01.040","article-title":"Development and validation of a sensitive liquid chromatography\/electrospray tandem mass spectrometry assay for the quantification of olanzapine in human plasma","volume":"41","author":"Nirogi","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0025","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.apsb.2012.02.009","article-title":"LC\u2013MS\/MS assay for olanzapine in human plasma and its application to a bioequivalence study","volume":"2","author":"Patel","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.forsciint.2013.03.021_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1570-0232(02)00164-2","article-title":"Determination of olanzapine in plasma by high-performance liquid chromatography using ultra-violet absorbance detection","volume":"773","author":"Dusci","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2013.03.021_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0378-4347(98)00205-9","article-title":"Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs","volume":"714","author":"Olesen","year":"1998","journal-title":"J. Chromatogr. B: Biomed. Sci. Appl."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00007691-200108000-00023","article-title":"Instability of olanzapine in calf serum","volume":"23","author":"Lakso","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jchromb.2005.11.032","article-title":"Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection","volume":"830","author":"Sachse","year":"2006","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/anatox\/35.8.583","article-title":"Comparison of the stability of stock solutions of drugs of abuse and other drugs stored in a freezer, refrigerator, and at ambient temperature for up to one year","volume":"35","author":"Karinen","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jchromb.2003.11.037","article-title":"Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"802","author":"Zhou","year":"2004","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0060","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jpba.2009.07.007","article-title":"Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC\u2013MS","volume":"50","author":"Choong","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1570-0232(02)01003-6","article-title":"High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose","volume":"788","author":"Titier","year":"2003","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007691-200408000-00019","article-title":"Assessment of storage and transport stability of new antidepressant and antipsychotic drugs for a nationwide TDM service","volume":"26","author":"Heller","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2011.02.022","article-title":"Assessment of the stability of 30 antipsychotic drugs in stored blood specimens","volume":"215","author":"Saar","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2125.2003.01821.x","article-title":"Comparability of whole-blood and plasma clozapine and norclozapine concentrations","volume":"56","author":"Flanagan","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FTD.0b013e31815f4e72","article-title":"Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients","volume":"30","author":"Hermida","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00216-011-5187-9","article-title":"Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs","volume":"401","author":"Remane","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0095","doi-asserted-by":"crossref","unstructured":"D.S. Fisher, S.J. Partridge, S.A. Handley, L. Couchman, P.E. Morgan, R.J. Flanagan, LC\u2013MS\/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood, Forensic Sci. Int., http:\/\/dx.doi.org\/10.1016\/j.forsciint.2013.02.010, in press.","DOI":"10.1016\/j.forsciint.2013.02.010"},{"key":"10.1016\/j.forsciint.2013.03.021_bib0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/dta.1337","article-title":"The analysis of antipsychotic drugs in human matrices using LC\u2013MS(\/MS)","volume":"4","author":"Saar","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1080\/10826070903320582","article-title":"Study of separation and extraction conditions for five neuroleptic drugs by an LLE\u2013HPLC\u2013DAD method in human plasma","volume":"32","author":"Madej","year":"2009","journal-title":"J. Liq. Chromatogr. Rel. Technol."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0110","unstructured":"FDA\/CDER Guidance for Industry: Bioanalytical Method Validation, 2001, available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070107.pdf (accessed 18.0711)."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bmc.1572","article-title":"Strategies in quantitative LC\u2013MS\/MS analysis of unstable small molecules in biological matrices","volume":"25","author":"Li","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cyto.2012.05.019","article-title":"Effect of anticoagulants on multiplexed measurement of cytokine\/chemokines in healthy subjects","volume":"60","author":"Biancotto","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.forsciint.2013.03.021_bib0125","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jpba.2004.01.005","article-title":"A study of matrix effects on an LC\/MS\/MS assay for olanzapine and desmethyl olanzapine","volume":"35","author":"Chin","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00007691-199906000-00014","article-title":"Clozapine monitoring: plasma or serum levels?","volume":"21","author":"Kaladjian","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.forsciint.2012.01.029","article-title":"Identification of 2-hydroxymethyl-olanzapine as a novel degradation product of olanzapine","volume":"220","author":"Saar","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0140","first-page":"81","article-title":"Disposition and biotransformation of the antipsychotic agent olanzapine in humans","volume":"25","author":"Kassahun","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.forsciint.2013.03.021_bib0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/clinchem\/27.1.203","article-title":"In vitro stability of nomifensine in plasma","volume":"27","author":"McIntyre","year":"1981","journal-title":"Clin. Chem."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073813001746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073813001746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T21:08:17Z","timestamp":1595624897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073813001746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0379073813001746"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2013.03.021","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2013.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}